Related Experiment Video
Updated: Nov 24, 2025

Monitoring Hippo Signaling Pathway Activity Using a Luciferase-based Large Tumor Suppressor LATS Biosensor
Published on: September 13, 2018
The tumor suppressor LATS2 reduces v-Src-induced membrane blebs in a kinase activity-independent manner
Masayoshi Ikeuchi1,2, Ryuzaburo Yuki1, Youhei Saito1
1Department of Biochemistry & Molecular Biology, Kyoto Pharmaceutical University, Kyoto, Japan.
Abstract:
When cells with excess DNA, such as tetraploid cells, undergo cell division, it can contribute to cellular transformation via asymmetrical chromosome segregation-generated genetic diversity. Cell cycle progression of tetraploid cells is suppressed by large tumor suppressor 2 (LATS2) kinase-induced inhibitory phosphorylation of the transcriptional coactivator Yes-associated protein (YAP). We recently reported that the oncogene v-Src induces tetraploidy and promotes cell cycle progression of tetraploid cells by suppressing LATS2 activity. We explore here the mechanism by which v-Src suppresses LATS2 activity and the role of LATS2 in v-Src-expressing cells. LATS2 was directly phosphorylated by v-Src and the proto-oncogene c-Src, resulting in decreased LATS2 kinase activity. This kinase-deficient LATS2 accumulated in a YAP transcriptional activity-dependent manner, and knockdown of either LATS2 or the LATS2-binding partner moesin-ezrin-radixin-like protein (Merlin) accelerated v-Src-induced membrane bleb formation. Upon v-Src expression, the interaction of Merlin with LATS2 was increased possibly due to a decrease in Merlin phosphorylation at Ser518, the dephosphorylation of which is required for the open conformation of Merlin and interaction with LATS2. LATS2 was colocalized with Merlin at the plasma membrane in a manner that depends on the Merlin-binding region of LATS2. The bleb formation in v-Src-expressing and LATS2-knockdown cells was rescued by the reexpression of wild-type or kinase-dead LATS2 but not the LATS2 mutant lacking the Merlin-binding region. These results suggest that the kinase-deficient LATS2 plays a role with Merlin at the plasma membrane in the maintenance of cortical rigidity in v-Src-expressing cells, which may cause tumor suppression.
Insights
The oncogene v-Src suppresses LATS2 kinase activity, promoting cell cycle progression in tetraploid cells. Kinase-deficient LATS2, along with Merlin, maintains cortical rigidity at the plasma membrane, potentially suppressing tumors.
Area of Science:
- Cell Biology
- Molecular Oncology
- Cancer Research
Background:
- Tetraploid cells can drive cellular transformation through genetic diversity.
- Large tumor suppressor 2 (LATS2) kinase normally suppresses tetraploid cell cycle progression by inhibiting YAP.
- The oncogene v-Src was previously shown to induce tetraploidy and promote cell cycle progression by suppressing LATS2.
Purpose of the Study:
- To elucidate the mechanism by which v-Src suppresses LATS2 activity.
- To investigate the role of LATS2 in v-Src-expressing cells.
Main Methods:
- Investigated direct phosphorylation of LATS2 by v-Src and c-Src.
- Analyzed the localization and interaction of LATS2 and Merlin in v-Src-expressing cells.
- Utilized knockdown and reexpression of LATS2 mutants to assess functional roles.
Main Results:
- v-Src directly phosphorylates and inhibits LATS2 kinase activity.
- Kinase-deficient LATS2 accumulates and interacts with Merlin at the plasma membrane.
- LATS2 and Merlin cooperate at the plasma membrane to maintain cortical rigidity, suppressing bleb formation.
Conclusions:
- v-Src-mediated suppression of LATS2 kinase activity is crucial for promoting cell cycle progression in tetraploid cells.
- Kinase-deficient LATS2, in complex with Merlin, plays a novel role in maintaining plasma membrane integrity.
- This interaction may represent a tumor suppressive mechanism in v-Src-expressing cells.
More Related Videos
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
11:32Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
Related Concept Videos
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Abnormal Proliferation
PI3K/mTOR/AKT Signaling Pathway
Receptor Tyrosine Kinases
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...